Talisic, Baby Girl .

HRN: 29-02-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/17/2026
05/24/2026
IV
40MG
Q24
SEPSIS
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines